AutoGenomics has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics.
Ensemble Discovery is developing a new class of therapeutics - the Ensemblins™, orally bioavailable small molecule macrocyclic compounds that have the potential to behave like biologics and can disrupt protein-protein interactions. We have two complementary platforms that provide access to these molecules. Firstly, we use our proprietary DNA-Programmed Chemistry™ (DPC™) platform to generate hundreds of thousands of these molecules for rapid screening. Secondly, we have highly developed methods for the synthesis of Ensemblins as discrete molecules using conventional chemistry.
Agilent Life Sciences and Chemical Analysis is a leading global provider of instrumentation, supplies, software and services to the life science and chemical analysis markets.
Agilent provides the worlds most complete, most reliable laboratory productivity solutions, optimized for your applications and workflows. Agilent's complete menu of services includes instrument maintenance and repair, compliance support, software integration, consulting and educationall designed to protect your investment and assure the highest possible levels of uptime.